|
|
|
|
LEADER |
03169nam a22004695i 4500 |
001 |
978-1-4020-6289-6 |
003 |
DE-He213 |
005 |
20150519191503.0 |
007 |
cr nn 008mamaa |
008 |
100301s2007 ne | s |||| 0|eng d |
020 |
|
|
|a 9781402062896
|9 978-1-4020-6289-6
|
024 |
7 |
|
|a 10.1007/978-1-4020-6289-6
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a R-RZ
|
072 |
|
7 |
|a MBGR
|2 bicssc
|
072 |
|
7 |
|a MED000000
|2 bisacsh
|
082 |
0 |
4 |
|a 610
|2 23
|
245 |
1 |
0 |
|a Nanomaterials and Nanosystems for Biomedical Applications
|h [electronic resource] /
|c edited by M. Reza Mozafari.
|
264 |
|
1 |
|a Dordrecht :
|b Springer Netherlands,
|c 2007.
|
300 |
|
|
|a XVII, 162 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a Micro and Nano Systems in Biomedicine and Drug Delivery -- New Lipid- and Glycolipid-Based Nanosystems for Targeted Gene Delivery: Cholenims, Glycoclips, Glycolipids and Chitosan -- Artificial Implants – New Developments and Associated Problems -- Niosomes as Nanocarrier Systems -- Starch – A Potential Biomaterial for Biomedical Applications -- Alternative Applications for Drug Delivery: Nasal and Pulmonary Routes -- An Overview of Liposome-Derived Nanocarrier Technologies -- Uptake Studies of Free and Liposomal Sclareol by Mcf-7 and H-460 Human Cancer Cell Lines -- Release Advantages of A Liposomal Dendrimer-Doxorubicin Complex, Over Conventional Liposomal Formulation of Doxorubicin -- Applications of Light and Electron Microscopic Techniques in Liposome Research.
|
520 |
|
|
|a "Nanomaterials and Nanosystems for Biomedical Applications" brings together under a single cover various aspects of functional bioengineered materials and nanostructured biomaterials including commonly used implants and sustained release nanodevices. The book includes expert reviews on the advances and current problems associated with the implants and nanodevices along with their applications in medicine, pharmaceutics, cancer therapy, gene transfer and drug delivery. The editor, M. R. Mozafari (PhD), has been working in the field of nanobiotechnology for the past 14 years and has produced more than 60 publications. The book also describes the key research parameters pertaining to major technologies employed in the field. To put it in perspective, all important aspects dealing with the chemistry, physics, biology and engineering of nanostructured biomaterials and their applications in nanobiotechnology are covered.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Biotechnology.
|
650 |
|
0 |
|a Biomaterials.
|
650 |
|
0 |
|a Nanotechnology.
|
650 |
1 |
4 |
|a Biomedicine.
|
650 |
2 |
4 |
|a Biomedicine general.
|
650 |
2 |
4 |
|a Biotechnology.
|
650 |
2 |
4 |
|a Biomaterials.
|
650 |
2 |
4 |
|a Nanotechnology.
|
700 |
1 |
|
|a Mozafari, M. Reza.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9781402062889
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-1-4020-6289-6
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SBL
|
950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|